COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients
Mary J Kasten, Brian D Lahr, Anusha Parisapogu, Zachary A Yetmar, John C O’Horo, Robert Orenstein, Pablo Moreno Franco, Raymund R Razonable, Paschalis Vergidis, Aditya S Shah, Mark J Enzler, David J Inwards, Philippe R Bauer · 2023
Read COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients by Mary J Kasten, Brian D Lahr, Anusha Parisapogu, Zachary A Yetmar, John C O’Horo, Robert Orenstein, Pablo Moreno Franco, Raymund R Razonable, Paschalis Vergidis, Aditya S Shah, Mark J Enzler, David J Inwards, Philippe R Bauer (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10692159.txt.
Description
Mary Kasten and colleagues follow COVID-19 in patients whose immune systems were blunted by a common drug class, in this study from twenty twenty-three. Anti-CD20 drugs wipe out B cells and are used for cancers and autoimmune disease. Plasma from recovered donors was widely tried as a treatment, but its value in such patients was disputed.
The team found one hundred forty-four adults at Mayo Clinic sites who caught COVID after recent anti-CD20 therapy. About a third were in hospital within two weeks, and nearly half within ninety days. Ninety-day mortality ran near fifteen percent. How long since the last drug dose made no difference. Neither did donor plasma: those who got it within two weeks fared no better on any outcome than those who did not. The authors call for trials of early antiviral mixes in this group, rather than more faith in plasma.
Catalog record
| CREATOR | Mary J Kasten, Brian D Lahr, Anusha Parisapogu, Zachary A Yetmar, John C O’Horo, Robert Orenstein, Pablo Moreno Franco, Raymund R Razonable, Paschalis Vergidis, Aditya S Shah, Mark J Enzler, David J Inwards, Philippe R Bauer |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |